"Assembly Bio’s herpes drug shows 94% drop in viral shedding" was originally created and published by Clinical Trials Arena, ...

Growing research shows common herpes viruses may raise dementia risk, challenging previous skepticism and opening new paths ...

Medically reviewed by Steffini Stalos, DO Key Takeaways There is no cure for herpes, but antiviral medicines can help reduce ...

Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.

It’s estimated that, globally, around 67% of people under 50 have herpes simplex virus type 1 (HSV-1) infection, the main cause of oral herpes or cold sores, and around 13% have herpes simplex ...

The herpes simplex virus (HSV) impacts millions globally, yet it remains surrounded by stigma and misinformation. Advances in research have expanded our understanding of the virus, leading to ...

Mounting evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease and dementia, according to a systematic review of published studies ...

So once someone gets infected, they've got the virus for life. In the 15-to-49-year-old age range, 1 in 5 people are living with a genital herpes infection — that's about 846 million people.

The herpes simplex virus is very common and up to 80 percent of Swedish adults may be infected. The infection is lifelong, but the symptoms can come and go over different periods of life.

The herpes simplex virus employs sophisticated biological mechanisms that enable transmission without visible symptoms, creating challenges for both clinical management and public health efforts.

Many adults are infected with herpes simplex virus type 1 (HSV-1), a lifelong condition that often manifests as annoying cold sores but has the potential, albeit rare, to lead to more serious ...

GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clinical trials. Moderna and Pfizer's partner BioNTech are still ...